Rinnová Markéta, Nefzi Adel, Houghten Richard A
Torrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, CA 92121, USA.
Bioorg Med Chem Lett. 2002 Nov 4;12(21):3175-8. doi: 10.1016/s0960-894x(02)00678-9.
Modulation of opioid activity was accomplished for analogues of Leu-enkephalin through incorporation of a 4-imidazolidinone moiety. The peptide backbone was constrained via a methylene bridge between two neighboring amides within its regular peptide sequence, which was expected to disrupt the secondary structure of the original molecule. Five positional analogues of Leu-enkephalin based on the same sequence and different location of the imidazolidinone-constrict were designed, synthesized, and examined for their affinity to micro-, delta- and kappa-opioid receptors.
通过引入4-咪唑烷酮部分实现了亮氨酸脑啡肽类似物的阿片样物质活性调节。肽主链通过其常规肽序列中两个相邻酰胺之间的亚甲基桥进行约束,这有望破坏原始分子的二级结构。基于相同序列和咪唑烷酮-缩合剂不同位置设计、合成并检测了亮氨酸脑啡肽的五个位置类似物对微、δ和κ阿片样物质受体的亲和力。